Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,006
Closed -$211K 226
2022
Q2
$211K Sell
1,006
-962
-49% -$205K 0.14% 241
2022
Q1
$477K Sell
1,968
-441
-18% -$107K 0.18% 209
2021
Q4
$627K Sell
2,409
-900
-27% -$234K 0.2% 204
2021
Q3
$872K Buy
3,309
+106
+3% +$29K 0.29% 166
2021
Q2
$790K Sell
3,203
-990
-24% -$208K 0.23% 197
2021
Q1
$814K Buy
4,193
+625
+18% +$125K 0.23% 199
2020
Q4
$758K Buy
+3,568
New +$711K 0.23% 198
2020
Q2
Sell
-2,299
Closed -$339K 321
2020
Q1
$339K Buy
2,299
+1,340
+140% +$213K 0.08% 261
2019
Q4
$149K Sell
959
-7,801
-89% -$1.12M 0.03% 299
2019
Q3
$1.18M Sell
8,760
-652
-7% -$85.4K 0.22% 194
2019
Q2
$1.15M Buy
9,412
+760
+9% +$84.2K 0.22% 184
2019
Q1
$900K Buy
8,652
+1,010
+13% +$104K 0.18% 203
2018
Q4
$870K Buy
7,642
+6,992
+1,076% +$749K 0.2% 186
2018
Q3
$75K Buy
+650
New +$71.2K 0.02% 304

Other funds holding RMD

Fort LP's RMD Position: Q3 2022 in Review

Fort LP sold out of ResMed (RMD) in Q3 2022, closing a stake of 1,006 shares — an estimated $211K sold.

Fort LP first reported a position in RMD in Q3 2018 and held it in 14 quarters. The position peaked at $1.18M in Q3 2019. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Fort LP reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
  • Fort LP sold 1,006 ResMed shares in Q3 2022, an estimated $211K.
  • Fort LP first reported a position in ResMed in Q3 2018 and held it in 14 quarters.
  • Fort LP's ResMed position peaked at $1.18M in Q3 2019.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Fort LP's 13F filing for Q3 2022, filed 10 Nov 2022.